Predictive Oncology Inc. (Ticker: POAI) is an innovative healthcare organization headquartered in Eagan, Minnesota, focused on revolutionizing cancer treatment through advanced predictive analytics and personalized medicine. Leveraging proprietary technologies and a robust database, the company aims to enhance patient outcomes by providing tailored therapeutic strategies that guide clinicians and researchers. With a strong emphasis on oncology innovation, Predictive Oncology is strategically positioned to transform the cancer care landscape, delivering actionable insights that significantly improve therapeutic decision-making and treatment efficacy.